Medical
Immunotherapy and Older Mesothelioma Patients: Real-World Data Shows 25% Lower Survival vs. Clinical Trials
David Foster
March 24, 2026
Real-world data reveals older mesothelioma patients on immunotherapy survive 25% less than clinical trial participants. Learn what the gap means for treatment decisions.
12 min read 7 FAQs
Read